Life Science Nation Newsletter  |  July 31, 2014  |  Issue 73

COMPANIES   |   INVESTORS   |   CONFERENCES
Learn More about LSN
In This Issue

July Roundup: 76 Mandates

 

RESI Announces Medical Device Strategics Panel

READ MORE

Early Stage Investors and Your Website 
Life Science Investor Mandates (Jul. 23 - Jul. 30)
Seeking 510k Devices and Diagnostics

Seeking Molecular Diagnostics

Seeking Life Science Opportunities in US and Asia

LSN Videos
[Book] The Life Science Executive's Fundraising Manifesto
Recent News
in collaboration with the UMASS Boston VDC

"Reinventing Investment"
"Beyond Venture Capital"
Quick Links


July Roundup: 76 Mandates
By Lucy Parkinson, Senior Research Manager, LSN

 

It's been a busy month here at LSN, with our researchers gathering 76 mandates from a wide variety of investors between July 1 and July 25. (See Exhibit 1.) 


Engineering the Future of Healthcare: RESI Conference Announces Medical Device Strategics Panel 
By Tom Crosby, RESI Conference Manager, LSN

The medtech space currently represents an attractive opportunity for a large number of investors, as recent LSN data shows that there is a steady interest in medical devices. This all-new RESI panel focuses on investors who seek emerging medtech opportunities. LSN has assembled a stellar group of top medtech investors to give attendees a better understanding of how these investors view the market, evaluate a sector and parse early stage medtech firms and technologies.


 

Moderated by Karthik Ranganathan, Strategic Innovation at Becton, Dickinson & Company, the audience will hear from:

  • Josh Phillips, Managing Partner, Catalyst Health Ventures
  • Juan Carlos Serna, Vice President, HPA Ventures
  • Lawrence Cho, Senior Director, Corporate Strategy & BD, Medtronic
  • Aaron Sandoski, Co-Founder & Managing Director, Norwich Ventures
Early Stage Investors and Your Website

By Michael Quigley, Director of Research, LSN

 

When speaking with investors during the past week, I made a point of asking what information they look for on a life science company's website in order to determine if they want to have a more in-depth conversation. The responses tended to be very similar despite coming from investors in multiple categories, including traditional VCs and family offices. Here are the six items that were most cited.

A Clear and Concise Description of What a Company Is Trying to Achieve

Your firm's tagline should be the first thing that catches investors' attention when they come to your website. In approximately four to eight words, your tagline should describe simply and adroitly your value added. You should elaborate on this in an elevator pitch, which describes your technology and mission in four to six sentences...

 


 www.lifesciencenation.com

Address: 9B Hamilton Place, Boston, MA, 02108, USA

Phone: +1 (617) 600-0668

Email: Info@lifesciencenation.com

follow us: Follow us on Twitter View our profile on LinkedIn